Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma.

Ganbin Qiu,Jincan Chen,Weixiong Liao,Yonghui Liu,Zhongyan Wen,Yue Zhao

Frontiers in oncology（2023）

引用 0|浏览0

暂无评分

摘要

Gadoxetic acid-enhanced MRI combined with T1 mapping and several clinical factors can preoperatively predict Ki-67 LI with high accuracy, and thus enable risk stratification and personalized treatment of HCC patients.

查看译文

关键词

hepatocellular carcinoma,mri,acid-enhanced

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要